Senior Director and Head, Health Economics and Outcomes Research, Alkermes
Amy K. O'Sullivan, Ph.D. is Head of Health Economics and Outcomes Research (HEOR) at Alkermes, Inc. O'Sullivan is a health economist with over 20 years of experience conducting health economics and outcomes research for the pharmaceutical industry. Over the course of her career, O'Sullivan has led the development and conduct of burden-of-illness studies, retrospective database analyses, patient-reported outcomes research, trial-based economic evaluations, and pharmacoeconomic models. Her research has been global in nature and spans a wide range of therapeutic areas including autoimmune conditions, cardiovascular disease, central nervous system/behavioral health disorders, metabolic disorders, musculoskeletal conditions, oncology, respiratory disease, women's health, and rare diseases. Prior to joining Alkermes, O'Sullivan held senior leadership positions at Vertex Pharmaceuticals, IMS Health, and OptumInsight, where she led research teams and provided scientific expertise on a range of HEOR projects in support of product reimbursement in jurisdictions around the world. O'Sullivan has authored studies published in Pharmacoeconomics, Value in Health, Managed Care, Journal of Medical Economics, International Journal of Technology Assessment in Health Care, and American Journal of Managed Care, among others. She has presented the results of her research at pharmacoeconomic and clinical congresses around the globe. O'Sullivan holds a BA in Economics and English from Boston College and Ph.D. in Health Economics from the Johns Hopkins University Bloomberg School of Public Health. She also holds an adjunct faculty position at the Boston University School of Public Health.